Min Yin

Min Yin has extensive work experience in finance and operations roles. Their most recent position was as the Senior Vice President of Operations at I-Mab Biopharma, starting in December 2020. Prior to that, they worked at Smith & Nephew as the Senior Business Unit Director for AWM from January 2020 to December 2020, and as the Senior Finance Director for Greater China from November 2017 to January 2020.

Before joining Smith & Nephew, Min Yin held various roles at SciClone Pharmaceuticals, including Vice President of Commerce, Market Access, and Key Account from August 2015 to November 2017, Vice President of Internal Audit from February 2014 to August 2015, and Vice President of Compliance and Internal Audit from November 2011 to January 2014.

They also worked as the Finance Director for Greater China at Leica Microsystems from November 2010 to October 2011, and as the Senior Director of Finance and Commercial at Novartis Oncology China from September 2009 to April 2010.

Min Yin's earlier experience includes the role of Finance Director for China and Hong Kong at Boston Scientific from July 2004 to September 2009, and Finance Director for China at Valmont Industries from May 1996 to June 2004.

Min Yin received a Bachelor of Arts in Business Administration (BABS) with a major in Accounting from the University of Nebraska at Omaha in the years 1990 to 1994. Following that, Min Yin pursued a Master of Business Administration (MBA) from Rutgers University - Newark from the years 2000 to 2002. Min Yin's education history also includes a Certified Public Accountant (CPA) certification. However, specific information about the institution, month, and year of obtaining the CPA certification is not provided.